Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Highlights
Radiochemistry
Radiopharmacy
Review
Journal
EJNMMI radiopharmacy and chemistry
ISSN: 2365-421X
Titre abrégé: EJNMMI Radiopharm Chem
Pays: England
ID NLM: 101714628
Informations de publication
Date de publication:
26 Apr 2022
26 Apr 2022
Historique:
received:
10
02
2022
accepted:
15
02
2022
entrez:
26
4
2022
pubmed:
27
4
2022
medline:
27
4
2022
Statut:
epublish
Résumé
The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals and also a contribution in relation to MRI-agents is included. Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.
Sections du résumé
BACKGROUND
BACKGROUND
The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
RESULTS
RESULTS
This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals and also a contribution in relation to MRI-agents is included.
CONCLUSION
CONCLUSIONS
Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.
Identifiants
pubmed: 35471681
doi: 10.1186/s41181-022-00162-3
pii: 10.1186/s41181-022-00162-3
pmc: PMC9043146
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
9Subventions
Organisme : NCI NIH HHS
ID : R01 CA225837
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL109448
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL153606
Pays : United States
Organisme : NHLBI NIH HHS
ID : R33 HL154125
Pays : United States
Informations de copyright
© 2022. The Author(s).
Références
Dalton Trans. 2021 Nov 23;50(45):16451-16458
pubmed: 34709268
Nucl Med Biol. 2019 Mar;70:39-45
pubmed: 30836255
Dalton Trans. 2014 Oct 21;43(39):14851-7
pubmed: 25164373
J Nucl Med. 2021 Oct;62(10):1398-1405
pubmed: 33579804
J Med Chem. 2021 Nov 11;64(21):15846-15857
pubmed: 34708646
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
EJNMMI Radiopharm Chem. 2021 Nov 14;6(1):37
pubmed: 34778932
Chem Commun (Camb). 2018 Sep 6;54(72):10179-10182
pubmed: 30137103
J Nucl Med. 2021 Apr;62(4):561-567
pubmed: 32859701
J Exp Clin Cancer Res. 2010 Jun 08;29:66
pubmed: 20529313
Radiology. 2015 May;275(2):490-500
pubmed: 25706654
Exp Mol Pathol. 2013 Dec;95(3):350-56
pubmed: 24422232
Sci Rep. 2019 Oct 16;9(1):14835
pubmed: 31619702
Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):871-880
pubmed: 34537893
J Med Chem. 2022 Jan 13;65(1):497-506
pubmed: 34937337
Chem Sci. 2021 Jan 29;12(10):3733-3742
pubmed: 34163647
J Nucl Med. 2015 Apr;56(4):523-9
pubmed: 25745094
Nucl Med Biol. 2021 Mar-Apr;94-95:38-45
pubmed: 33493787
Clin Cancer Res. 2021 Apr 1;27(7):1932-1940
pubmed: 33408249
EJNMMI Radiopharm Chem. 2021 Aug 21;6(1):26
pubmed: 34417894
EJNMMI Radiopharm Chem. 2018;3(1):3
pubmed: 29503860
J Nucl Med. 1976 Jun;17(6):480-7
pubmed: 816999
EJNMMI Radiopharm Chem. 2021 Aug 26;6(1):30
pubmed: 34436693
Molecules. 2019 Jan 18;24(2):
pubmed: 30669256
Molecules. 2019 Aug 07;24(16):
pubmed: 31394799
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):73-86
pubmed: 32588089
Bioorg Med Chem. 2014 Mar 1;22(5):1700-7
pubmed: 24503274
Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):972-983
pubmed: 33063250
J Nucl Med. 2021 Aug 1;62(8):1075-1081
pubmed: 33277398
Nucl Med Biol. 2020 Nov - Dec;90-91:31-40
pubmed: 32979725
J Am Chem Soc. 2021 Aug 4;143(30):11751-11758
pubmed: 34297566
Clin Cancer Res. 2021 Feb 15;27(4):911-912
pubmed: 33328345
Nat Chem. 2013 Nov;5(11):941-4
pubmed: 24153372
J Nucl Med. 2020 Sep;61(9):1331-1336
pubmed: 32060216
Molecules. 2021 Sep 21;26(18):
pubmed: 34577170
Nucl Med Biol. 2022 Jan-Feb;104-105:38-46
pubmed: 34856450
Angew Chem Int Ed Engl. 2022 Feb 7;61(7):e202114203
pubmed: 34889014
Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1148-1156
pubmed: 34651220
J Nucl Med. 2007 Dec;48(12):1945-50
pubmed: 18006614
J Labelled Comp Radiopharm. 2021 Oct;64(12):466-476
pubmed: 34382259
J Org Chem. 2021 Oct 15;86(20):14121-14130
pubmed: 34505779
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):732-742
pubmed: 34297193
Mol Pharm. 2017 Feb 6;14(2):523-532
pubmed: 28094532
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3386-3399
pubmed: 33712870